NCT05163756View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

PHASE3CompletedINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

April 27, 2021

Study Completion Date

May 10, 2021

Conditions
Gastritis AcuteGastritis Chronic
Interventions
DRUG

DW1903

q.d. PO, DW1903 + Placebo of DW1903-R1

DRUG

DW1903-R1

q.d. PO, Placebo of DW1903 + DW1903-R1

Trial Locations (1)

02841

Korea University Ansan Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY